TAMBOCOR

This brand name is authorized in Australia, Ecuador, Estonia, Finland, Germany, Hong Kong SAR China, Ireland, Israel, Japan, Malta, Mexico, Netherlands, New Zealand, Romania, Singapore, South Africa, UK.

Active ingredients

The drug TAMBOCOR contains one active pharmaceutical ingredient (API):

1	Flecainide UNII M8U465Q1WQ - FLECAINIDE ACETATE
	Flecainide acetate is a Class IC antiarrhythmic agent used for the treatment of severe symptomatic life-threatening ventricular arrhythmias and supraventricular arrhythmias. Electrophysiologically, flecainide is a local anaesthetic-type (Class IC) of antiarrhythmic compound. It is an amide type of local anaesthetic, being structurally related to procainamide and encainide in so far as these agents are also benzamide derivatives.
	Read more about Flecainide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C01BC04	Flecainide	C Cardiovascular system → C01 Cardiac therapy → C01B Antiarrhythmics, class I and III → C01BC Antiarrhythmics, class Ic
Discover more medicines within C01BC04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	1088G, 1090J
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	01416671, 02489761, 02489778, 02489784, 03837098, 03837106, 04355378, 04355384, 04355390, 04921027, 04965941, 04965958, 13331916, 13515651, 13899798, 17638385
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	4446-MEE-1018
EE	Ravimiamet	1032231, 1032242, 1032253, 1070626, 1070637, 1421806, 1695168, 1756942
FI	Lääkealan turvallisuus- ja kehittämiskeskus	009146, 009490, 068437, 068445, 068452
GB	Medicines & Healthcare Products Regulatory Agency	14006, 162620
HK	Department of Health Drug Office	24395, 60853, 60854
IE	Health Products Regulatory Authority	49077, 49093
IL	מִשְׂרַד הַבְּרִיאוּת	2869, 4189, 7300
JP	医薬品医療機器総合機構	2129009C1023, 2129009F1020, 2129009F2026, 2129406A1030
MT	Medicines Authority	AA565/65304, AA729/30901, MA1507/02001
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	009M84
NL	Z-Index G-Standaard	13882252
NL	Z-Index G-Standaard, PRK	19712, 20419, 38253, 67237, 67245, 67253, 70661
NZ	Medicines and Medical Devices Safety Authority	4069, 4070, 4071, 4072, 4074, 4075
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68727001, W68727002, W68727003, W68728001, W68728002, W68728003
SG	Health Sciences Authority	01726P
ZA	Health Products Regulatory Authority	37/6.2/0198, 37/6.2/0199, 37/6.2/0200, 37/6.2/0201, S/6.2/16, S/6.2/17